Jeevan Scientific Technology D Balance Sheet Annual

Trade

BSE: 538837 | NSE: - | ISIN: INE237B01018 | Sector: Biotechnology & Drugs

52.05 +1.48 (2.93%)Updated : 27 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash Equivalents	0.54	6.83	1.35	3.26
Short Term Investments	2.98	5.28	7.78	2.30
Cashand Short Term Investments	3.53	12.11	37.55	8.51
Accounts Receivable- Trade Net	12.29	11.68	7.61	14.45
Total Receivables Net	16.82	14.44	14.44	19.93
Total Inventory	1.09	1.10	1.46	3.46
Other Current Assets Total	3.23	1.12	0.50	1.97
Total Current Assets	24.67	29.19	53.94	33.87
Property/ Plant/ Equipment Total- Net	23.94	20.84	14.10	15.88
Intangibles Net	5.53	6.04	4.98	11.49
Long Term Investments	0.73	0.64	-	-
Other Long Term Assets Total	12.99	9.22	0.00	0.60
Total Assets	67.87	65.92	77.88	65.98
Accounts Payable	2.15	2.66	2.00	3.26
Current Portof LT Debt/ Capital Leases	3.79	3.00	2.93	2.52
Other Currentliabilities Total	3.27	3.86	11.97	17.03
Total Current Liabilities	9.21	11.39	22.15	22.87
Long Term Debt	8.05	3.51	4.37	7.77
Capital Lease Obligations	1.57	2.29	-	-
Total Long Term Debt	9.62	5.80	4.37	7.77
Total Debt	13.41	10.10	12.54	10.35
Minority Interest	0.20	0.23	-	-
Other Liabilities Total	0.41	0.31	0.27	0.32
Total Liabilities	19.44	17.73	27.30	30.95
Common Stock Total	15.48	15.48	15.30	15.30
Retained Earnings( Accumulated Deficit)	32.95	12.33	35.28	19.72
Total Equity	48.43	48.19	50.58	35.02
Total Liabilities Shareholders' Equity	67.87	65.92	77.88	65.98
Total Common Shares Outstanding	1.55	1.55	1.53	1.53
Tangible Book Valueper Share Common Eq	27.71	27.23	29.81	15.38
Prepaid Expenses	-	0.42	-	-
Property/ Plant/ Equipment Total- Gross	-	40.74	-	-
Accumulated Depreciation Total	-	-19.90	-	-
Accrued Expenses	-	0.58	-	-
Notes Payable/ Short Term Debt	-	1.29	5.25	0.05
Deferred Income Tax	-	0.00	0.50	0.00
Additional Paid- In Capital	-	20.38	-	-
Cash	-	-	28.42	2.96
Note Receivable- Long Term	-	-	4.87	4.13